A new device provides rapid hemorrhage management, has minimal inflammatory effects, and provides infection control. Most notably, it has tunable rates of biodegradation, making it usable for both ...

NEW YORK, NY, Sept. 14, 2023--A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and ...

Please provide your email address to receive an email when new articles are posted on . Treatment success for the JADA system was high for both vaginal and cesarean births. Overall, 2.8% of women in ...

Organon, a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of ...

A newly published clinical study reveals a potential breakthrough in the treatment of refractory postpartum hemorrhage (PPH), the leading cause of maternal death worldwide. Led by Dr. Yevheniia ...

A multi-faceted device for effectively treating deep, non-compressible, and irregularly-shaped wounds has been engineered by the scientists at the Terasaki Institute for Biomedical Innovation (TIBI).

There are currently many hemorrhage control products available such as cotton or gauze bandages, powders, and tourniquets. These are usually used with compression on shallow, more uniformly shaped ...

A study led by obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients. A study led by ...